ResearcherTUM KlinikumActive in the last 2 years
Maximilian Kießler
Matched on ORCID iD 0000-0001-9932-2269; OpenAlex author ID A5069360744. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 43
2023: 2 papers · 2024: 2 papers
Papers 4
- A retrospective, multicentric, nationwide analysis of the impact of splenectomy on survival of pancreatic cancer patients. Co-author DOI 10.1007/s00423-024-03570-y↗
- Neoadjuvant chemotherapy is associated with suppression of the B cell-centered immune landscape in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fimmu.2024.1378190↗
- Arterial Resection for Pancreatic Cancer: Feasibility and Current Standing in a High-Volume Center. Co-author DOI 10.1097/as9.0000000000000302↗
- Phenotype screens of murine pancreatic cancer identify a Tgf-α-Ccl2-paxillin axis driving human-like neural invasion. Co-author DOI 10.1172/jci166333↗
Closest collaborators
The 25 strongest of 43 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- İhsan Ekin Demir · 4 shared papers, 2023–2024 · strength 0.60
- Paper Neoadjuvant chemotherapy is associated with suppression of the B cell-centered immune landscape in pancreatic ductal ad… DOI 10.3389/fimmu.2024.1378190↗
- Paper Arterial Resection for Pancreatic Cancer: Feasibility and Current Standing in a High-Volume Center. DOI 10.1097/as9.0000000000000302↗
- Paper A retrospective, multicentric, nationwide analysis of the impact of splenectomy on survival of pancreatic cancer patien… DOI 10.1007/s00423-024-03570-y↗
- Carmen Mota Reyes · 3 shared papers, 2023–2024 · strength 0.44
- Paper Neoadjuvant chemotherapy is associated with suppression of the B cell-centered immune landscape in pancreatic ductal ad… DOI 10.3389/fimmu.2024.1378190↗
- Paper A retrospective, multicentric, nationwide analysis of the impact of splenectomy on survival of pancreatic cancer patien… DOI 10.1007/s00423-024-03570-y↗
- Paper Phenotype screens of murine pancreatic cancer identify a Tgf-α-Ccl2-paxillin axis driving human-like neural invasion. DOI 10.1172/jci166333↗
- Guralp Onur Ceyhan · 3 shared papers, 2023–2024 · strength 0.42
- Paper Arterial Resection for Pancreatic Cancer: Feasibility and Current Standing in a High-Volume Center. DOI 10.1097/as9.0000000000000302↗
- Paper A retrospective, multicentric, nationwide analysis of the impact of splenectomy on survival of pancreatic cancer patien… DOI 10.1007/s00423-024-03570-y↗
- Paper Phenotype screens of murine pancreatic cancer identify a Tgf-α-Ccl2-paxillin axis driving human-like neural invasion. DOI 10.1172/jci166333↗
- Marc Eric Martignoni · 2 shared papers, 2023–2024 · strength 0.30
- Rüdiger Göß · 2 shared papers, 2023–2024 · strength 0.30
- Ilaria Pergolini · 2 shared papers, 2023–2024 · strength 0.30
- Stephan Schorn · 2 shared papers, 2023–2024 · strength 0.30
- Alexander Novotny · 2 shared papers, 2023–2024 · strength 0.30
- Helmut Friess · 2 shared papers, 2023–2024 · strength 0.30
- Okan Safak · 2 shared papers, 2023–2024 · strength 0.30
- Helmut Frieß · 2 shared papers, 2023–2024 · strength 0.30
- Paper Neoadjuvant chemotherapy is associated with suppression of the B cell-centered immune landscape in pancreatic ductal ad… DOI 10.3389/fimmu.2024.1378190↗
- Paper Phenotype screens of murine pancreatic cancer identify a Tgf-α-Ccl2-paxillin axis driving human-like neural invasion. DOI 10.1172/jci166333↗
- Alexander Muckenhuber · 2 shared papers, 2023–2024 · strength 0.30
- Paper Neoadjuvant chemotherapy is associated with suppression of the B cell-centered immune landscape in pancreatic ductal ad… DOI 10.3389/fimmu.2024.1378190↗
- Paper Phenotype screens of murine pancreatic cancer identify a Tgf-α-Ccl2-paxillin axis driving human-like neural invasion. DOI 10.1172/jci166333↗
- Lei Ren · 2 shared papers, 2023 · strength 0.28
- Casper W.F. van Eijck · 1 shared paper, 2024 · strength 0.18
- Luise Rupp · 1 shared paper, 2024 · strength 0.18
- Marc Schmitz · 1 shared paper, 2024 · strength 0.18
- Casper H.J. van Eijck · 1 shared paper, 2024 · strength 0.18
- Werner Hartwig · 1 shared paper, 2024 · strength 0.14
- Tim R. Glowka · 1 shared paper, 2024 · strength 0.14
- Tobias Keck · 1 shared paper, 2024 · strength 0.14
- Michael B. Ghadimi · 1 shared paper, 2024 · strength 0.14
- Soeren Torge Mees · 1 shared paper, 2024 · strength 0.14
- Karl J. Oldhafer · 1 shared paper, 2024 · strength 0.14
- Waldemar H. Uhl · 1 shared paper, 2024 · strength 0.14
- Detlef Klaus Bartsch · 1 shared paper, 2024 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.